![]() ![]() To date, thousands of 340B covered entities have used Kalderos' Discount Hub solution to participate in the good faith inquiry process and resolve concerns related to duplicate discounts. But the free-flowing system of data enabled by Kalderos relieves all stakeholders of the arduous process of tracking down misapplied discounts.ĭrug discount programs are critical for the support they provide safety-net healthcare providers and their patients, many of whom live in vulnerable communities. Outside of their financial impact, inaccurate discount payments also lead to mounting administrative responsibilities for manufacturers and 340B covered entities that can redirect valuable resources away from patients. Manufacturers contend with widely varying rates of inaccurate drug discount claims and resulting overpayment some assessments identify more than 10% potentially inaccurate claims and some as low as 2%. Full transparency and information are mission critical to attaining these goals and enabling our healthcare system to better serve patients."Īcross dozens of assessments produced for prospective customers of Kalderos' MDRP Discount Monitoring solution, Kalderos identified an average of 5% potentially inaccurate discounts, mainly duplicate discounts between Medicaid and 340B. "The findings in our third annual report are significant," said Kalderos CEO Brent Dover. "We urge all stakeholders in drug discount programs to work together on building cooperation and trust. As Kalderos partners with an increasing number of drug manufacturers to process even bigger data sets, that number continues to grow. ![]() Between 2016 and Q1 2023, Kalderos' MDRP Discount Monitoring solution identified nearly $1 billion in inaccurate discount requests. ![]() In response to this systemwide challenge, Kalderos' MDRP Discount Monitoring solution analyzes and validates claims data while flagging potential duplicate discounts and other inaccurate claims. Across the healthcare industry, outdated technology, inadequate infrastructure and intractable data silos make it difficult to prevent these misapplied discounts, resulting in drug manufacturer overpayment. InSync Mobile can be added for mobile access to patient charting, e-prescribing and scheduling on all handheld devices.As the Medicaid Drug Rebate Program (MDRP), 340B Drug Pricing Program and other similar programs expand, so do the volume and cost of duplicate discounts and other inaccurate drug discount claims. Moreover, users to create their own custom fields and customized layouts because of the intuitive user interface package offered. The need to eradicate duplicate records and provides management and workflow throughout the practice is fulfilled by the integration of PM and EMR by InSync which delivers a medical office solution.įeatures such as scheduling calendars, e-prescribing, electronic claims submission, quick physical exam charts, and reconciliation reports allow InSync’s system to be flexible to any practice’s requirements. ![]() This ONC-ATCB guaranteed and CCHIT affirmed ambulatory EMR and practice management(PM) product is for both solo practices and bigger multi-specialty areas.Ī decision to opt from purchasing an upfront license or using a web-based subscription is given by the InSync. InSync Healthcare Solutions EMR/PM empowers healthcare experts to provide healthcare that is in consistent with regulatory requirements. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |